A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2006
11/08/2006	CN1857201A Slow released anticancer injection with both blood vessel inhibitor and its synergist
11/08/2006	CN1857198A Tumor treating methyl cantharidimide injection and freeze dried powder for injection and their preparing process
11/08/2006	CN1283802C Recombinant adenovirus and its application in malignant tumor treatment
11/08/2006	CN1283664C Erythropoietin conjugate
11/08/2006	CN1283662C Antagonistic anti-hFAS ligand human antibodies and fragments thereof
11/08/2006	CN1283655C Philinopside E, a novel antineoplastic compound in pentacta quadrangulasis
11/08/2006	CN1283652C Isolated nucleic acid molecule encoding cancer associated antigen, antigen itself, and uses thereof
11/08/2006	CN1283651C Oligonucleotide and adriacin covalent coupled compound and preparing method thereof
11/08/2006	CN1283648C Antineoplastic platinum complex
11/08/2006	CN1283637C Substd. N-Benzyl-indol-3-yl glyoxylic acid derivs. having anti-tumoral effect
11/08/2006	CN1283635C Heterocyclic retinoid compounds
11/08/2006	CN1283621C Alkyl urea vitamin A protagonist I
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/08/2006	CN1283599C Pinellia tuber total organic acid and extraction method, and its use in preparing drugs
11/08/2006	CN1283319C Tumor vaccine constituting method by combining dendritic cell multiplication and chemotaxis factor and suicide gene
11/08/2006	CN1283298C Pharmaceutical composition for treating acute myocardial ischemia its preparing method
11/08/2006	CN1283272C Anticancer medicine and preparing method thereof
11/08/2006	CN1283267C Ginseng stem and leaf total saponin oral disintegration tablet and its preparing method
11/08/2006	CN1283264C Staphylococcus aureus metabolic product medicine oral preparation and its use
11/08/2006	CN1283254C Use of 23-hydroxy betulic acid in preparing administrative and/or preventive drugs for inhibiting blood vessel formation
11/08/2006	CN1283250C Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/08/2006	CN1283248C Combinations comprising epothilones and pharmaceutical uses thereof
11/08/2006	CN1283244C Oral preparation of diterpene compounds against cancers and preparing method and use thereof
11/08/2006	CN1283243C Taxane class derivative based pharmaceutical compositions
11/08/2006	CN1283242C Freeze-dried pharmaceutical preparation
11/08/2006	CN1283238C Use of alkannin in preparing medicine for treating tumor disease
11/08/2006	CN1283237C Curcumin and phosphatide composite and its preparation method
11/08/2006	CN1283236C Application of Hehoupu phenol in preparing antitumour multi medicinal tolerant medicine
11/07/2006	US7132533 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
11/07/2006	US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006	US7132513 Bifunctional chelating agent
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006	US7132417 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
11/07/2006	US7132415 Especially a substituted azetidinone compound
11/07/2006	US7132392 administering to mammals peptides having angiostatic activity, that inhibit hepatocyte growth factor induced cell migration and binding between intracellular transducers and receptor protein tyrosine kinases; anticarcinogenic agents
11/07/2006	US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006	US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	US7132238 Method of determining a chemotherapeutic regimen based on ERCC1 expression
11/07/2006	US7132232 Diagnosing mammary gland cancer; obtain mammary gland fluid, detect preferential virus in fluid, evaluate for cancer
11/07/2006	US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006	US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006	US7132109 Administering to the subject a vaccine comprising component against which an immune response is desired to be induced; administering to the subject a heat shock protein preparation which does not display immunogenicity of the component
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2226436C Generation of immune responses to prostate-specific antigen (psa)
11/07/2006	CA2192824C Pyridone-carboxylic acid derivatives, processes for the preparation thereof and anti-tumor agents containing the pyridone-carboxylic acid derivatives
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/07/2006	CA2091967C Monoclonal anti-ganglioside antibody, its preparation and use as a tumor therapeutic agent
11/02/2006	WO2006116733A2 Protein kinase inhibitors
11/02/2006	WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006	WO2006116401A1 C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators
11/02/2006	WO2006116341A1 Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes
11/02/2006	WO2006116246A2 Method of treating cd30 positive lymphomas
11/02/2006	WO2006115633A2 Cyanine-chlorotoxin conjugate and method for intra-operative fluorescent visualization of cancer
11/02/2006	WO2006115509A2 Small molecule immunopotentiators and assays for their detection
11/02/2006	WO2006115413A2 Methods and means for the treatment of hpv induced intraepithelial neoplasias
11/02/2006	WO2006115293A1 NOVEL BLOCK COPOLYMER USED FOR PREPARING pH-RESPONSIVE POLYMER MICELLE, AND METHOD FOR PRODUCING SAME
11/02/2006	WO2006115273A1 Method for treating body fluid
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2006115187A1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/02/2006	WO2006115170A1 Hsv1-hf10 virus therapy for head-and-neck cancer
11/02/2006	WO2006114702A2 Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor
11/02/2006	WO2006114652A1 Ethanolic extract of animal origin combined with enzymes acts therapeutically on malignant and other diseases.
11/02/2006	WO2006114520A2 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
11/02/2006	WO2006114336A1 Fluorinated 3'-deoxythymidine derivatives, a method for their preparation and their use
11/02/2006	WO2006114333A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
11/02/2006	WO2006114307A1 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
11/02/2006	WO2006114180A1 Novel aza- heterocycles serving as kinase inhibitors
11/02/2006	WO2006114115A1 Combination of antibodies and glucocorticoids for treating cancer
11/02/2006	WO2006114065A2 Use of compounds to inhibit neoplasia
11/02/2006	WO2006114064A2 Use of compounds to enhance processivity of telomerase
11/02/2006	WO2006089150A3 Antiangiogenic agents with aldesleukin
11/02/2006	WO2006087756A3 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
11/02/2006	WO2006087077A3 Hsp90-inhibiting triazole derivatives
11/02/2006	WO2006086716A3 Donor lymphocyte infusion of activated t cells for the treatment of cancer
11/02/2006	WO2006072809A3 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
11/02/2006	WO2006033007A3 Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
11/02/2006	WO2005113515A8 Pyrimidines for use as plk inhibitors
11/02/2006	WO2005107748A3 Method of tonic treatment with oxyphenbutazone derivatives
11/02/2006	WO2005092385A3 Combination therapy of azd2171 and a taxane
11/02/2006	WO2005092303A3 Combination therapy with azd2171 and 5-fu and/or cpt-11
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247316 Food supplement
11/02/2006	US20060247307 imino compound as antiinflammatory agent, anticarcinogenic agent for treating chronic inflammation and cancers; activating peroxisome proliferator-activated receptor
11/02/2006	US20060247302 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247284 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy
11/02/2006	US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds

1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 2211